Aspirin and cancer risk: a summary review to 2007.

Cristina Bosetti, Silvano Gallus, Carlo La Vecchia

Research output: Contribution to journalArticlepeer-review


Aspirin has been associated with a reduced risk of colorectal cancer and--based on limited evidence--to cancers of the oesophagus, stomach, breast, ovary and lung. The role of aspirin on other cancers, such as pancreatic, prostate and bladder cancer and non-Hodgkin's lymphomas and myeloma is less clear, and an increase of risk has been suggested for kidney cancer. For most cancer sites, however, significant heterogeneity between studies, and particularly between study design, was found, with a reduction in risk generally stronger in case-control studies than in cohort ones.

Original languageEnglish
Pages (from-to)231-251
Number of pages21
JournalRecent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
Publication statusPublished - 2009

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Aspirin and cancer risk: a summary review to 2007.'. Together they form a unique fingerprint.

Cite this